Athanor Capital’s Immunogen Inc IMGN Stock Holding History

Athanor Capital’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-27,183	Closed	-$220K	–	849
2021 Q1	$220K	Sell	27,183 -2,429	-8%	-$19.8K	0.01%	692
2020 Q4	$191K	Buy	+29,612	New	+$173K	﹤0.01%	667

Other funds holding IMGN

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Athanor Capital's IMGN Position: Q2 2021 in Review

Athanor Capital sold out of Immunogen Inc (IMGN) in Q2 2021, closing a stake of 27,183 shares — an estimated $220K sold.

Athanor Capital first reported a position in IMGN in Q4 2020 and held it in 2 quarters. The position peaked at $220K in Q1 2021. 214 funds tracked by Wall St. Rank hold IMGN as of Q2 2021.

Athanor Capital reported no remaining Immunogen Inc position as of Q2 2021 after selling out during the quarter.
Athanor Capital sold 27,183 Immunogen Inc shares in Q2 2021, an estimated $220K.
Athanor Capital first reported a position in Immunogen Inc in Q4 2020 and held it in 2 quarters.
Athanor Capital's Immunogen Inc position peaked at $220K in Q1 2021.
214 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2021.

Based on Athanor Capital's 13F filing for Q2 2021, filed 16 Aug 2021.